Knowledge Center

Article / 2011

What is Special About Inhalation APIs?

Interview: Carla Vozone, Director, Business Development

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Read article here

Also in the Knowledge Center

Related content

IPAC-RS FDA Roundtable

Carla Vozone speaker at the webinar "A Conversation with the FDA: Perspectives in the Time of COVID-19", November 2nd, 2020

Date: 02/11/2020 - 10:30
Location: online
Event
View

Webinar - Dry Powder Inhaler Formulation Development

Webinar Title: Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization

Date: 04/12/2018 - 16:00
Location: online
Event
View